Home > Products > CEA & TNFα
> Human Anti-CEA x Anti-TNFα Bispecific Antibody (IgG-IgG)
Human Anti-CEA x Anti-TNFα Bispecific Antibody (IgG-IgG) (CAT#: BSIG-H309)
Anti-CEA x Anti-TNFα Bispecific Antibody (IgG-IgG) is designed to be generated by crosslinking two full length IgGs, anti-CEA and anti-TNFα parental antibodies. A stable linkage is formed between the two antibodies. This BsAb can retarget cytokine (TNFα) to tumor cells. It is designed for the research of Breast cancer; Ovary cancer; Colon cancer; Lung cancer therapy.
There are currently no customer reviews or questions for Human Anti-CEA x Anti-TNFα Bispecific Antibody (IgG-IgG) (BSIG-H309). Click the button below to contact us or submit your feedback about this product.